FDA approves first anti-C1s antibody, targeting innate immunity for rare anaemia

被引：0

|

作者：

Mullard, Asher

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2022年 / 21卷 / 04期

关键词：

D O I：

10.1038/d41573-022-00049-7

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：249 / 249

页数：1

相关论文

共 50 条

[1] FDA approves first anti-C1s antibody, targeting innate immunity for rare anaemia
Asher Mullard
Nature Reviews Drug Discovery, 2022, 21 : 249 - 249
[2] FDA approves first anti-ANGPTL3 antibody, for rare cardiovascular indication
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (04) : 251 - 251
[3] FDA approves first anti-ANGPTL3 antibody, for rare cardiovascular indication
Asher Mullard
Nature Reviews Drug Discovery, 2021, 20 : 251 - 251
[4] FDA approves first anti-IL-36 receptor antibody for rare skin disease
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (11) : 786 - 786
[5] FDA approves first anti-IL-36 receptor antibody for rare skin disease
Asher Mullard
Nature Reviews Drug Discovery, 2022, 21 : 786 - 786
[6] FDA approves first anti-TFPI antibody for haemophilia A and B
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (12) : 884 - 884
[7] TNT003, a Novel Anti-C1s Monoclonal Antibody, Inhibits Anti-HLA Antibody Induced Complement Deposition
Thomas, K.
Valenzuela, N.
Parry, G.
Panicker, S.
Reed, E.
TRANSPLANTATION, 2014, 98 : 461 - 461
[8] FDA approves anti-CD3 antibody to delay type 1 diabetes onset
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (01) : 6 - 7
[9] FDA approves anti-CD3 antibody to delay type 1 diabetes onset
Asher Mullard
Nature Reviews Drug Discovery, 2023, 22 : 6 - 7
[10] TNT003, a Novel Anti-C1s Monoclonal Antibody, Inhibits Anti-HLA Antibody Induced Complement Deposition.
Thomas, K.
Valenzuela, N.
Parry, G.
Panicker, S.
Reed, E.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 461 - 461

← 1 2 3 4 5 →